ATYR logo

ATYR
aTyr Pharma, Inc

13,478
Mkt Cap
$76.73M
Volume
3.68M
52W High
$7.29
52W Low
$0.64
PE Ratio
-0.94
ATYR Fundamentals
Price
$0.7831
Prev Close
$0.745
Open
$0.7225
50D MA
$0.7921
Beta
0.71
Avg. Volume
3.62M
EPS (Annual)
-$0.8621
P/B
0.96
Rev/Employee
$3,983.05
Loading...
Loading...
News
all
press releases
aTyr Pharma, Inc. (NASDAQ:ATYR) Given Consensus Rating of "Hold" by Brokerages
Shares of aTyr Pharma, Inc. (NASDAQ:ATYR - Get Free Report) have received a consensus rating of "Hold" from the eight brokerages that are currently covering the firm, Marketbeat Ratings reports. One...
MarketBeat·18d ago
News Placeholder
More News
News Placeholder
ATYR Deadline: ATYR Investors with Losses Have Opportunity to Lead aTyr Pharma, Inc. Securities Fraud Lawsuit
ATYR Deadline: ATYR Investors with Losses Have Opportunity to Lead aTyr Pharma, Inc. Securities Fraud Lawsuit ATYR Deadline: ATYR Investors with Losses Have Opportunity to Lead aTyr Pharma, Inc...
PR Newswire·24d ago
News Placeholder
FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of aTyr Pharma
Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against aTyr Pharma, Inc. (aTyr or the Company) (NASDAQ: ATYR) and reminds investors of the December 8...
Business Wire·24d ago
News Placeholder
ATYR LAWSUIT ALERT: The Gross Law Firm Notifies aTyr Pharma, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline
ATYR LAWSUIT ALERT: The Gross Law Firm Notifies aTyr Pharma, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline ATYR LAWSUIT ALERT: The Gross Law Firm Notifies aTyr Pharma, Inc. Investors...
PR Newswire·24d ago
News Placeholder
Investors who lost money on aTyr Pharma, Inc.(ATYR) should contact Levi & Korsinsky about pending Class Action - ATYR
Investors who lost money on aTyr Pharma, Inc.(ATYR) should contact Levi & Korsinsky about pending Class Action - ATYR Investors who lost money on aTyr Pharma, Inc.(ATYR) should contact Levi...
PR Newswire·27d ago
News Placeholder
ATYR 3-DAY DEADLINE ALERT: Hagens Berman Urges aTyr Pharma Investors to Act by Dec. 8 Deadline in Suit Over Trial Failure
ATYR 3-DAY DEADLINE ALERT: Hagens Berman Urges aTyr Pharma Investors to Act by Dec. 8 Deadline in Suit Over Trial Failure ATYR 3-DAY DEADLINE ALERT: Hagens Berman Urges aTyr Pharma Investors to Act...
PR Newswire·27d ago
News Placeholder
Deadline Soon: aTyr Pharma Inc. (ATYR) Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz About Securities Fraud Lawsuit
The Law Offices of Frank R. Cruz reminds investors of the upcoming December 8, 2025 deadline to participate as a lead plaintiff in the securities fraud class action lawsuit filed on behalf of...
Business Wire·28d ago
News Placeholder
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of aTyr Pharma
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of aTyr Pharma INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of...
PR Newswire·28d ago
News Placeholder
aTyr Pharma, Inc. Sued for Securities Law Violations - Contact The Gross Law Firm Before December 8, 2025 to Discuss Your Rights - ATYR
aTyr Pharma, Inc. Sued for Securities Law Violations - Contact The Gross Law Firm Before December 8, 2025 to Discuss Your Rights - ATYR aTyr Pharma, Inc. Sued for Securities Law Violations - Contact...
PR Newswire·28d ago
News Placeholder
Shareholders that lost money on aTyr Pharma, Inc.(ATYR) should contact Levi & Korsinsky about pending Class Action - ATYR
Shareholders that lost money on aTyr Pharma, Inc.(ATYR) should contact Levi & Korsinsky about pending Class Action - ATYR Shareholders that lost money on aTyr Pharma, Inc.(ATYR) should contact Levi...
PR Newswire·1mo ago
<
1
2
...
>

Latest ATYR News

View

Advertisement|Remove ads.

Advertisement|Remove ads.